These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9568908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Capture and identification of folding intermediates of cystinyl proteins by cyanylation and mass spectrometry.
    Watson JT, Yang Y, Wu J.
    J Mol Graph Model; 2001; 19(1):119-28. PubMed ID: 11381521
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The disulfide folding pathway of human epidermal growth factor.
    Chang JY, Schindler P, Ramseier U, Lai PH.
    J Biol Chem; 1995 Apr 21; 270(16):9207-16. PubMed ID: 7721838
    [Abstract] [Full Text] [Related]

  • 5. Probing the folding pathways of long R(3) insulin-like growth factor-I (LR(3)IGF-I) and IGF-I via capture and identification of disulfide intermediates by cyanylation methodology and mass spectrometry.
    Yang Y, Wu J, Watson JT.
    J Biol Chem; 1999 Dec 31; 274(53):37598-604. PubMed ID: 10608814
    [Abstract] [Full Text] [Related]

  • 6. Determination of the disulfide structure of sillucin, a highly knotted, cysteine-rich peptide, by cyanylation/cleavage mass mapping.
    Qi J, Wu J, Somkuti GA, Watson JT.
    Biochemistry; 2001 Apr 17; 40(15):4531-8. PubMed ID: 11294620
    [Abstract] [Full Text] [Related]

  • 7. The disulfide structure of denatured epidermal growth factor: preparation of scrambled disulfide isomers.
    Chang JY, Li L.
    J Protein Chem; 2002 Mar 17; 21(3):203-13. PubMed ID: 12018622
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro folding of methionine-arginine human lyspro-proinsulin S-sulfonate-disulfide formation pathways and factors controlling yield.
    Chen S, Adijanto L, Wang NH.
    Biotechnol Prog; 2010 Mar 17; 26(5):1332-43. PubMed ID: 20540164
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Optimization and applications of CDAP labeling for the assignment of cysteines.
    Pipes GD, Kosky AA, Abel J, Zhang Y, Treuheit MJ, Kleemann GR.
    Pharm Res; 2005 Jul 17; 22(7):1059-68. PubMed ID: 16028006
    [Abstract] [Full Text] [Related]

  • 13. In vitro refolding of human proinsulin. Kinetic intermediates, putative disulfide-forming pathway folding initiation site, and potential role of C-peptide in folding process.
    Qiao ZS, Min CY, Hua QX, Weiss MA, Feng YM.
    J Biol Chem; 2003 May 16; 278(20):17800-9. PubMed ID: 12624089
    [Abstract] [Full Text] [Related]

  • 14. Kinetic folding pathway of a three-disulfide mutant of bovine pancreatic ribonuclease A missing the [40-95] disulfide bond.
    Xu X, Scheraga HA.
    Biochemistry; 1998 May 19; 37(20):7561-71. PubMed ID: 9585571
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Disulfide linkages in the in vitro refolded intermediates of recombinant human macrophage-colony-stimulating factor: analysis of the sulfhydryl alkylation of free cysteine residues by fast-atom bombardment mass spectrometry.
    Glocker MO, Arbogast B, Milley R, Cowgill C, Deinzer ML.
    Proc Natl Acad Sci U S A; 1994 Jun 21; 91(13):5868-72. PubMed ID: 8016080
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.